These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7970503)

  • 1. Cyclic sequential endocrine therapy for advanced breast cancer using a combination of tamoxifen and megestrol acetate.
    Crawford DJ; George WD; Smith DC; Stewart M; Paul J; Leake RE
    Oncology; 1994 Oct; 51 Suppl 1():13-8. PubMed ID: 7970503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast cancer.
    Gill PG; Gebski V; Snyder R; Burns I; Levi J; Byrne M; Coates A
    Ann Oncol; 1993 Nov; 4(9):741-4. PubMed ID: 8280654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Megestrol acetate in advanced breast carcinoma after failure to tamoxifen and/or aminoglutethimide.
    Brufman G; Isacson R; Haim N; Gez E; Sulkes A
    Oncology; 1994; 51(3):258-61. PubMed ID: 8196908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of antiestrogen and progestogen therapy for initial treatment and consequences of their combination for second-line treatment of recurrent breast cancer.
    Paterson AH; Hanson J; Pritchard KI; Sansregret E; Dahrouge S; McDermot RS; Fine S; White DF; Trudeau M; Stewart DJ
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):52-62. PubMed ID: 2259927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group.
    Buzdar A; Jonat W; Howell A; Jones SE; Blomqvist C; Vogel CL; Eiermann W; Wolter JM; Azab M; Webster A; Plourde PV
    J Clin Oncol; 1996 Jul; 14(7):2000-11. PubMed ID: 8683230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Megestrol acetate: first-line therapy for advanced breast cancer.
    Johnson PA; Bonomi PD; Anderson KM; Wolter JM; Economou SG
    Semin Oncol; 1986 Dec; 13(4 Suppl 4):15-9. PubMed ID: 3798124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine effects of the combination of megestrol acetate and tamoxifen in the treatment of metastatic breast cancer.
    Alexieva-Figusch J; Blankenstein MA; de Jong FH; Lamberts SW
    Eur J Cancer Clin Oncol; 1984 Sep; 20(9):135-40. PubMed ID: 6434315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-line treatment with mitoxantrone, methotrexate, vincristine, and carboplatine (MIMOC) plus cyclical hormonotherapy with tamoxifen and megestrol acetate in advanced breast cancer.
    Kakolyris S; Samonis G; Koukourakis M; Vlachonicolis J; Kalbakis K; Agelaki S; Chalkiadakis G; Sanidas E; Tsiftsis D; Georgoulias V
    Am J Clin Oncol; 1999 Jun; 22(3):273-7. PubMed ID: 10362335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential hormone therapy for advanced breast cancer.
    Von Roenn JH; Bonomi PD; Gale M; Anderson KM; Wolter JM; Economou SG
    Semin Oncol; 1988 Apr; 15(2 Suppl 1):38-43. PubMed ID: 3368799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of curettage for postmenopausal vaginal bleeding in women treated with tamoxifen and megestrol acetate for progressive metastatic breast carcinoma.
    Logmans A; Mous HV; Bontenbal M; Beerman H; van Lent M
    Eur J Obstet Gynecol Reprod Biol; 1994 Sep; 56(3):173-6. PubMed ID: 7821489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Megestrol acetate v tamoxifen in advanced breast cancer: a phase III trial of the Piedmont Oncology Association (POA).
    Muss HB; Paschold EH; Black WR; Cooper MR; Capizzi RL; Christian R; Cruz JM; Jackson DV; Stuart JJ; Richards F
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):55-61. PubMed ID: 3883503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association.
    Muss HB; Wells HB; Paschold EH; Black WR; Cooper MR; Capizzi RL; Christian R; Cruz JM; Jackson DV; Powell BL
    J Clin Oncol; 1988 Jul; 6(7):1098-106. PubMed ID: 3292710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Megestrol and tamoxifen in patients with advanced endometrial cancer: an Eastern Cooperative Oncology Group Study (E4882).
    Pandya KJ; Yeap BY; Weiner LM; Krook JE; Erban JK; Schinella RA; Davis TE
    Am J Clin Oncol; 2001 Feb; 24(1):43-6. PubMed ID: 11232948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High- versus standard-dose megestrol acetate in women with advanced breast cancer: a phase III trial of the Piedmont Oncology Association.
    Muss HB; Case LD; Capizzi RL; Cooper MR; Cruz J; Jackson D; Richards F; Powell BL; Spurr CL; White D
    J Clin Oncol; 1990 Nov; 8(11):1797-805. PubMed ID: 2230868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential treatment of metastatic breast cancer with tamoxifen after megestrol acetate therapy and vice versa (a retrospective study).
    Alexieva-Figusch J; Van Putten WL; van Gilse HA; Blonk-vd Wijst J; Klijn JG
    Med Oncol Tumor Pharmacother; 1985; 2(2):69-75. PubMed ID: 4058078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Megestrol acetate in advanced breast carcinoma.
    Espie M
    Oncology; 1994 Oct; 51 Suppl 1():8-12. PubMed ID: 7970508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Megestrol acetate and aminoglutethimide/hydrocortisone in sequence or in combination as second-line endocrine therapy of estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group phase III trial.
    Russell CA; Green SJ; O'Sullivan J; Hynes HE; Budd GT; Congdon JE; Martino S; Osborne CK
    J Clin Oncol; 1997 Jul; 15(7):2494-501. PubMed ID: 9215817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised phase III cross-over study of tamoxifen versus megestrol acetate in advanced and recurrent breast cancer.
    Stuart NS; Warwick J; Blackledge GR; Spooner D; Keen C; Taylor AR; Tyrell C; Webster DJ; Earl H
    Eur J Cancer; 1996 Oct; 32A(11):1888-92. PubMed ID: 8943670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of megestrol acetate for the treatment of advanced breast cancer.
    Sedlacek SM
    Semin Oncol; 1988 Apr; 15(2 Suppl 1):3-13. PubMed ID: 3285483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of megestrol acetate with or without premarin in the treatment of potentially responsive metastatic breast cancer. A Study of the Eastern Cooperative Oncology Group (E2185).
    Cobau CD; Declercq K; Neuberg D; Ingle JN; Tormey DC
    Cancer; 1996 Feb; 77(3):483-9. PubMed ID: 8630955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.